Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

"Gan & Lee Pharmaceuticals"Announcement on Obtaining Notice of Approval for Drug Clinical Trial for the New Indication of GZC8072 Tablet

Sep 4, 2026 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining Notice of Approval for Drug Clinical Trial for the New Indication of GZC8072 Tablet

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Gan & Lee Pharmaceuticals Co., Ltd. Class A

"Gan & Lee Pharmaceuticals."Announcement on Release of Pledge of Certain Shares Held by Shareholder Holding More Than 5% of the SharesAug 27
"Gan & Lee Pharmaceuticals."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 26
"Gan & Lee Pharmaceuticals."Announcement on Obtaining Notice of Approval for Drug Clinical TrialsAug 25
"Gan & Lee Pharmaceuticals"Announcement on the Listing and Trading of Certain Restricted Shares from the Initial Public OfferingAug 19

All Gan & Lee Pharmaceuticals Co., Ltd. Class A news releases